Hear from Childhood Cancer Data Initiative (CCDI) staff members and learn about the initiative's plans and activities, including enhancements and additions to tools and platforms, and progress related to the upcoming CCDI Rare Pediatric Cancer Initiative.

Apply your data science experience to help make a difference in cancer health disparities research and accelerate progress towards cancer health equity across the globe.

Learn about adverse reactions to some cancer immunotherapies and immune-modulating drugs, and hear about the development of safety models to identify the risks and patterns of these reactions. Just register for the third course of the 2023 SITC-NCI Computational Immuno-Oncology Webinar Series.

Attend this virtual Cancer Moonshot℠ seminar junior investigator session and hear Drs. Adam Spannaus and Chenchen Zhu describe how they use analyses and AI models to support two Cancer Moonshot initiatives.

Need a new approach for making your clinical trial more efficient and accessible to more people? Maybe you need a way to translate your technology into clinical practice? Join this symposium to learn how a systems biology approach might help.

During this webinar, Dr. Subhashini Jagu and Mr. Zack Dorman will provide an overview of how to use this platform and highlight its various use cases.

Are you a recent or late-stage graduate? Perhaps you’re a postdoc or a faculty member in the early stages of your career? Even if you’re finished with school, you can still gain a lot of knowledge by networking with other NCI junior investigators at this 2-day event.

Learn about new methods designed to identify tumor-specific targets not recognized by the human immune system.

Register for this three-day virtual seminar series, hosted by an NCI artificial intelligence (AI) working group, and be a part of a multi-national conversation on AI’s role in advancing biomedical research.

Interested in new informatics tools and data integration? Attend this seminar to learn more from New York University’s Dr. Itai Yanai.